Jaime E. Hallak
Jaime E. Hallak
Dirección de correo verificada de fmrp.usp.br
TítuloCitado porAño
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug
AW Zuardi, JAS Crippa, JEC Hallak, FA Moreira, FS Guimarães
Brazilian journal of medical and biological research 39 (4), 421-429, 2006
4312006
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients
MM Bergamaschi, RHC Queiroz, MHN Chagas, DCG De Oliveira, ...
Neuropsychopharmacology 36 (6), 1219, 2011
4072011
Síndrome de burnout ou estafa profissional e os transtornos psiquiátricos
TR Trigo, CT Teng, JEC Hallak
Archives of Clinical Psychiatry 34 (5), 223-233, 2007
2932007
Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco–magnetic resonance imaging study
JFW Deakin, J Lees, S McKie, JEC Hallak, SR Williams, SM Dursun
Archives of general psychiatry 65 (2), 154-164, 2008
2822008
Confiabilidade de" Entrevista Clínica Estruturada para o DSM-IV--Versão Clínica" traduzida para o português.
CM Del-Ben, JAA Vilela, JAS Crippa, JEC Hallak, CM Labate, AW Zuardi
Revista Brasileira de Psiquiatria, 2001
2802001
Neuroimaging in social anxiety disorder: a systematic review of the literature
MC Freitas-Ferrari, JEC Hallak, C Trzesniak, A Santos Filho, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 34 (4), 565-580, 2010
2592010
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
JAS Crippa, GN Derenusson, TB Ferrari, L Wichert-Ana, FLS Duran, ...
Journal of psychopharmacology 25 (1), 121-130, 2011
2532011
Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment
IB Chaudhry, J Hallak, N Husain, F Minhas, J Stirling, P Richardson, ...
Journal of psychopharmacology 26 (9), 1185-1193, 2012
2332012
Cannabidiol for the treatment of psychosis in Parkinson’s disease
AW Zuardi, JAS Crippa, JEC Hallak, JP Pinto, MHN Chagas, ...
Journal of Psychopharmacology 23 (8), 979-983, 2009
2282009
Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology
OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ...
American Journal of Psychiatry 174 (3), 216-229, 2016
2182016
Effects of cannabidiol (CBD) on regional cerebral blood flow
JA de Souza Crippa, AW Zuardi, GEJ Garrido, L Wichert-Ana, R Guarnieri, ...
Neuropsychopharmacology 29 (2), 417, 2004
2162004
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
FL Osório, RF Sanches, LR Macedo, RG Dos Santos, JP Maia-de-Oliveira, ...
Brazilian Journal of Psychiatry 37 (1), 13-20, 2015
1992015
Cannabidiol monotherapy for treatment-resistant schizophrenia
AW Zuardi, JEC Hallak, SM Dursun, SL Morais, RF Sanches, RE Musty, ...
Journal of Psychopharmacology 20 (5), 683-686, 2006
1912006
A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation
AW Zuardi, JA Crippa, JE Hallak, S Bhattacharyya, Z Atakan, ...
Curr Pharm Des 18 (32), 5131-40, 2012
1532012
Age and gender influence on maximal bite force and masticatory muscles thickness
M Palinkas, MSP Nassar, FA Cecílio, S Siéssere, M Semprini, ...
Archives of oral biology 55 (10), 797-802, 2010
1502010
Use of the Fonseca's questionnaire to assess the prevalence and severity of temporomandibular disorders in Brazilian dental undergraduates
K Nomura, M Vitti, AS Oliveira, TC Chaves, M Semprini, S Siéssere, ...
Brazilian dental journal 18 (2), 163-167, 2007
1502007
The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network
F Palhano-Fontes, KC Andrade, LF Tofoli, AC Santos, JAS Crippa, ...
PloS one 10 (2), e0118143, 2015
1462015
Is the full version of the AUDIT really necessary? Study of the validity and internal construct of its abbreviated versions
C Meneses‐Gaya, AW Zuardi, SR Loureiro, JEC Hallak, C Trzesniak, ...
Alcoholism: Clinical and Experimental Research 34 (8), 1417-1424, 2010
1452010
Effects of cannabidiol in the treatment of patients with Parkinson’s disease: an exploratory double-blind trial
MHN Chagas, AW Zuardi, V Tumas, MA Pena-Pereira, ET Sobreira, ...
Journal of Psychopharmacology 28 (11), 1088-1098, 2014
1402014
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study
RF Sanches, F de Lima Osório, RG dos Santos, LRH Macedo, ...
Journal of clinical psychopharmacology 36 (1), 77-81, 2016
1372016
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20